HHE Pathology and diagnostics supplement 2018 - Page 18

References 1 Ferlay J et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. 2 National Cancer Intelligence Network. Stage Breakdown by CCG 2014. London: NCIN; 2016. 3 Northern Ireland Cancer Registry, Queens University Belfast, Incidence by stage 2010–2014. Belfast: NICR; 2016. 4 Alexandrov LB et al. Signatures of mutational processes in human cancer. Nature 2013;500:415–21. 5 Howlader N et al. SEER Cancer Statistics Review, 1975–2014, based on November 2016 SEER data submission. Bethesda, MD: National Cancer Institute; 2017. https://seer.cancer.gov/ csr/1975_2014/ (accessed May 2018). 6 Johnson DH, Schiller JH, Bunn PA Jr. Recent clinical advances in lung cancer management. J Clin Oncol 2014;32:973–82. 7 Reck M et al. Management of non-small-cell lung cancer: recent developments. Lancet 2013;382:709–19. 8 Forde PM, Ettinger DS. Targeted therapy for non-small-cell lung cancer: past, present and future. Expert Rev Anticancer Ther 2013;13:745–8. 9 Ettinger DS. Ten years of progress in non-small cell lung cancer. J Natl Compr Canc Netw 2012;10:292–5. 10 Swanton C, Govindan R. Clinical implications of genomic discoveries in lung cancer. N Engl J Med 2016;374:1864–73. 11 Kris MG et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA 2014;311:1998–2006 12 Kwak EL et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N En YY L͌ΌML$ ˂L[\[YH]\\X\]ܚˈ\Z[]B[X[\ٚ[[و[˜Y[\[XK]\B MLLNM $L MHH][ Y[YX][ۈقH[ٛܛZ[SS PS\[ۂ[H[ۈX[[[[\]\H Mx$͋MHZ]XH][ ][\^]\H[ܚ\[ۋTԂܙY[[܈SS PS\[ۂ[ܚ\ˈ[[\\Œ MN8$̍ M[\[Y\ BHوHSX\܈[[\[K[ۘ M̍\NZZM8$ZZLMKMHS][ Hݙ[\[ۈو[S[[˜Y[\[XKܘXۘ MNM$͋N[][ T KPSBݙ[S\[ۈ\X[]\ۙܚ^[XܘX“ۘ MN x$M NHۙH][ T KPSHݙ[\[ۈZ[Y[YYY[[˜Y[\[XKܘXۘ MN Nx$̌ZH][ \Hو\\KB\Y^ Y[\][ۂ\]Y[[]XS\[ۂ[\XH[ YYHHو]Y[]ۋ\X[ X[[[\ۘ\] M Nx$ H[ۈ][ \ [[Bܚ^[X\\[[\\H[S\]]H[[\[YY MNM$˂] ][  M  M  H܈]Y[]S\X\[YY[YۋBX[ X[[[\ QL RYJNH[KX\K[[X[ \H KLYK[]ۘ LMNL8$ ]\][ [X[X\\ܚ^[X[[X]YS\]]H۸$X[ X[[[\[YY MJN x$ ][XHH][][Y[ق[\\X[\XH[\H SB[X]ܜ[[X[\XYۛ\š[SX\[[Y[ \]]B[[\ۘ\]\ MΌx$ KH]U [HZY]Bˈܚ^[X\\[[\\B[Y[YS\]]B[[\[YY L͎ x$M [[X[\]B[[]ZX]HXXNB]Y]و\X[\\ˈ\]XYY L̊ N8$͌ XXH][ H[\XوX[[]X[\[›ۈZ[[]X[]H܈ KX[\[X[܈[]BXY^][ۈ[[ܙ\[[]HXY^][ۈ\^\˂Y]ˌ LL N $ Z[HH][ S]\\[š[ۜX[[[\[XNܜ[][ۈ]Y[[\[]]BR[T [XYۂ LMJ N x$͋H][ X[Y\BوS[[][\[Z\B[T܈[X[]X[ۂوS\X\[Y[˜Y[\[X\ˈܘXۘ L Ň$ [ZYH][ ]]H[X\[YSH\[X\[Y[[[ۋ\X[[[[\[\X][ۜ܂S[X]܈\\K[\ LLNJ NM8$KH[[\][ \[™܈SX\[[Y[[[Y[\[XNH][X[\\\\ۈق[[][\[Z\H[[ܙ\[[]HXY^][ۋ[] L̍ LNMM x$L˂̈ۙHH][ X\]BY[YX][ۈوS]]H[˜\[XH]Y[Έݙ[KBX\Y]]X]Y[ܙ\[B[]HXY^][ۈ[[œ\[H[[\[]]B[[][\[Z\KۙB MNLL ̌ Z[][ XYۛX[YBوHݙ[[H]]X]Y[[][[Z\H\^H܂]X[ۈوSX\[[Y[[[X\H[Y[\[XK[ۘ L̍Nx$L˂[H][ \ܙ[B]Y[[\\X[\XB[\H]\[[X\Bۋ\X[ X[[[\[Z\ܜ\ۙ[Y]\\\˂\]H L͌ N x$M H[YH][ [ܙX\YS[HH\[[\YX][ۈ\H\]Y[[ۋ\X[[[[\ܘXۘ LN͊ JNx$˂͈X]XHKST[R΂[H[]HۙH]]H\ܘXۘ MNLM8$L ]X][ ܙY[[܈Sš[ۋ\X[[[\[X\΂PM[ Q[XY\\ܛB\]X[H[ ]X[Y\B]T\X[Y[Y [[\ MNNL 8$KZY][ [X[\\[܈[X[ۈو]Y[][[\܈\Y\X[ܛX܈X\܈[[\\X[\XH[\B\[H[\H[X]ܜ΂[Y\X[Y]Hو[X[ۘH[ܜ[Y[وBYHو[Y\X[]\’[\][ۘ[\X][ۈ܈BYHو[[\\X][ۂ܈[X[\]HZY[[K[ۘ M͍̎$KHX[X][ \[[T[[[][\[ZX[YY\›وS]\[ ̍ ۋ\X[ B[[[\]X[XZ܂\ܙ[\ˈܘXۘ MNMx$ [YHRH][ \ܙ\[Y\˜]Y[T[[[][\[Z\H܂\\Y[وHS]\\B\X]Y]S8&ܙ\[x&KB]]HX\[[Y[܈BYH\H[X[XZ܈\YH܈[KPS\\]]X]YY\ˈ[ۘ MN̍8$ H[ۙ\HԈ][ [X[\\X\^][ۈو[[[X]ܞB^[ٚX؛\X[[ܜ]\]Y[S[H[B\[ۜ[\Hݙ[UX\[[Y[ [H\] MNNMM$͍˂ X\H][ \ۘ[^YۘHY[Yܘ]]HY ]Y]\]Y[[ΈH[YKB[YY LNΌLL\LLK [\ۈH][ ][Y[[[Y][ۈقH[X[[\[ZXٚ[[\\YۈX\][H\[[H\]Y[[ˈ][X LNL $K [\][ ^ Y[\][ۂ\]Y[[[ۘN[]X™XYۛ\\YX[ۈ[[\\YX][ۋ[YYB MN N HH][ ^ Y[\][ۂ\]Y[[܈[[\]\Bۘ LNĽ$͋ [ZYݘHH][ ]X[ۂوSX\[[Y[[ \X[]Y[ΈH][]HقY\[XYۛX\X\˂[[\ ML ΌM$̌˂ H][ X[][ۘ[[[\\وT[[[][\[Z\H]X[œ\H[ZX][[S\[ۂ]\[]\ۙܚ^[XX]Y[ ܘX“ۘ MLM8$L KZ\V[H][ [ܙ\[H[]HXY^][ۋ[[][\[Z\K[^ Y[\][ۈ\]Y[[™܈]X[ۈوSS PSœX\[[Y[[[[\ۘ\ MŇM$̌H[HH][ \Z[]B[ZXٚ[[Y[YY\BX]